2016
DOI: 10.1016/j.vaccine.2016.09.032
|View full text |Cite
|
Sign up to set email alerts
|

Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 32 publications
0
8
0
Order By: Relevance
“…The association between vaccination and development of CSVV has been reported in literature with various vaccines, namely: influenza, hepatitis A, hepatitis B, bacillus Calmette‐Guérin, anthrax, human papillomavirus, measles‐mumps‐rubella, and pneumococcal vaccines 25 …”
Section: Discussion and Review Of Literaturementioning
confidence: 95%
See 1 more Smart Citation
“…The association between vaccination and development of CSVV has been reported in literature with various vaccines, namely: influenza, hepatitis A, hepatitis B, bacillus Calmette‐Guérin, anthrax, human papillomavirus, measles‐mumps‐rubella, and pneumococcal vaccines 25 …”
Section: Discussion and Review Of Literaturementioning
confidence: 95%
“…The association between vaccination and development of CSVV has been reported in literature with various vaccines, namely: influenza, hepatitis A, hepatitis B, bacillus Calmette-Guérin, anthrax, human papillomavirus, measles-mumps-rubella, and pneumococcal vaccines. 25 Among the available COVID-19 vaccines, LCV has been reported with messenger RNA-based vaccines (BNT162b2 [Pfizer-BioNTech] 6,8-12 and mRNA-1273 [Moderna], 6,7 adenoviral vectorbased vaccines [ChAdOx1 nCoV-19; Oxford-AstraZeneca]), [13][14][15][16][17][18][19] and inactivated vaccines (Covaxin, 20,21 Sinovac, 22,23 and unspecified inactivated vaccines 24 ) (Table 1). Most of the reported vaccine-related cutaneous LCV were limited to the skin and only few were associated with systemic involvement.…”
Section: Discussion and Review Of Literaturementioning
confidence: 99%
“…In our series, purpuric cutaneous vasculitis secondary to inactivated vaccines, as Vaxzevria COVID-19 vaccination is more frequent, but coutaneus vasculitis is also reported following mRNA vaccines (Pfeitzer more prevalent : 6/23 cases). In this regard, in a study with large number of cases (2 vasculitis following Moderna vaccination is described, but only urticarial vasculitis) [22][23][24].…”
Section: Discussionmentioning
confidence: 98%
“…Vaccine-associated cutaneous vasculitis is a unusual event and the relationship between immunizations and vasculitis has to be determined. Cutaneous vasculitis after vaccination is reported most frequently after vaccine against in uenza, hepatitis A and hepatitisB, Bacillus Calmette-Guerin (BCG), anthrax, Human Papilloma Virus (HPV), measles-mumps-rubella (MMR) and pneumococci, described as triggers for vasculitis, particularly cutaneous vasculitis (18,19).…”
Section: Discussionmentioning
confidence: 99%